Stable expression of pertussis toxin in Bordetella bronchiseptica under the control of a tightly regulated promoter

Applied and Environmental Microbiology

Volumn 63, Issue 1, 1997, Pages 122-127

  Suarez, Antonio ^a,b   Staendner, Lothar H ^a   Rohde, Manfred ^a   Piatti, Gabriella ^c   Timmis, Kenneth N ^a   Guzmán, Carlos A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS TOXIN; RECOMBINANT PROTEIN;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BORDETELLA BRONCHISEPTICA; BORDETELLA PERTUSSIS; MOLECULAR CLONING; OPERON; PERTUSSIS; PHENOTYPE; TRANSPOSON;

EID: 0031032753     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.63.1.122-127.1997     Document Type: Article

References (42)

1. Auerswald, E. A., G. Ludwig, and H. Schaller. 1981. Structural analysis of Tn5. Cold Spring Harbor Symp. Quant. Biol. 45:107-113.
2. Baker, S. M., A. Masi, D.-F. Liu, B. K. Novitsky, and R. A. Deich. 1995. Pertussis toxin export genes are regulated by the ptx promoter and may be required for efficient translation of ptx mRNA in Bordetella pertussis. Infect. Immun. 63:3920-3926.
3. Burnette, W. N. 1981. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112:195-2113.
4. Burnette, W. N., V. L. Mar, W. Cieplak, C. F. Morris, K. T. Kaljot, K. S. Marchitto, R. K. Sachdev, C. Locht, and J. M. Keith. 1988. Direct expression of Bordetella pertussis toxin subunits to high levels in Escherichia coli. Bio/ Technology 6:699-706.
5. Cherry, J. D., P. A. Brunell, G. S. Golden, and D. T. Karzon. 1988. Report of the task force on pertussis and pertussis immunization. Pediatrics 81:937-984.
6. Covacci, A., and R. Rappuoli. 1993. Pertussis toxin export requires accessory genes located downstream from the pertussis toxin operon. Mol. Microbiol. 8:429-434.
7. Decker, M. D., K. M. Edwards, M. C. Steinhoff, M. B. Rennels, M. E. Pichichero, J. A. Englund, E. L. Anderson, M. A. Deloria, and G. F. Reed. 1995. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 96:557-566.
8. De Lorenzo, V., S. Fernández, M. Herrero, U. Jakubzik, and K. N. Timmis. 1993. Engineering of alkyl-and haloaromatic-responsive gene expression with mini-transposons containing regulated promoters of biodegradative pathways of Pseudomonas. Gene 30:41-46.
9. Edwards, K. M., B. D. Meade, M. D. Decker, G. F. Reed, M. B. Rennels, M. C. Steinhoff, E. L. Anderson, J. A. Englund, M. E. Pichichero, M. A. Deloria, and A. Deforest. 1995. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96:548-557.
10. Eidels, L., R. L. Proia, and D. A. Hart. 1983. Membrane receptors for bacterial toxins. Microbiol. Rev. 47:596-620.
11. Greco, D., S. Salmaso, P. Mastrantonio, M. Giuliano, A. Tozzi, A. Anemona, M. L. Ciofi degli Atti, A. Giammanco, P. Panei, W. C. Blackwelder, D. L. Klein, S. G. F. Wassilak, and the Progetto Pertosse Working Group. 1996. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
12. Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
13. Herrero, M., V. de Lorenzo, and K. N. Timmis. 1990. Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J. Bacteriol. 172:6557-6567.
14. Hewlett, E. L. K., K. T. Sauer, G. A. Myers, J. L. Cowell, and R. L. Guerrant. 1983. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect. Immun. 40:1198-1203.
15. Imaizumi, A., Y. Suzuki, S. Ono, H. Sato, and Y. Sato. 1983. Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis. Infect. Immun. 41:1138-1143.
16. Johnson, F. D., and D. L. Burns. 1994. Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis. J. Bacteriol. 76:5350-5356.
17. Kimura, A., K. T. Mountzouros, P. A. Schad, W. Cieplak, and J. L. Cowell. 1990. Pertussis toxin analog with reduced enzymatic and biological activities is a protective antigen. Infect. Immun. 58:3337-3347.
18. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-695.
19. Lee, C. K., A. Roberts, and S. Perrin. 1989. Expression of pertussis toxin in Bordetella bronchiseptica and Bordetella parapertussis carrying recombinant plasmids. Infect. Immun. 57:1413-1418.
20. Lee, S.-Y. 1996. High-cell density culture of Escherichia coli. Trends Biotechnol. 14:98-105.
21. Licari, P., C. R. Siber, and R. Swartz. 1991. Production of cell mass and pertussis toxin by Bordetella pertussis. J. Biotechnol. 20:117-130.
22. Locht, C., and J. M. Keith. 1986. Pertussis toxin gene: nucleotide sequence and genetic organization. Science 232:1258-1264.
23. Loosmore, S. M., G. R. Zealey, H. A. Boux, S. A. Cockle, K. Radika, R. E. F. Fahim, G. J. Zobrist, R. K. Yacoob, P. C. S. Chong, F. L. Yao, and M. H. Klein. 1990. Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine. Infect. Immun. 58:3653-3662.
24. Mégret, F., and J. E. Alouf. 1988. A simple novel approach for the purification of pertussis toxin. FEMS Microbiol. Lett. 51:159-162.
25. Nencioni, L., M. Pizza, M. Bugnoli, T. De Magistris, A. Di Tomasso, F. Giovannoni, R. Manetti, I. Marsili, C. Matteucci, D. Nucci, R. Olivieri, P. Pileri, R. Presentini, L. Villa, J. G. Kreeftenberg, S. Silvestri, A. Tagliabue, and R. Rappuoli. 1990. Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect. Immun. 58:1308-1315.
26. Nicosia, A., A. Bartoloni, M. Perugini, and R. Rappuoli. 1987. Expression and immunological properties of the five subunits of pertussis toxin. Infect. Immun. 55:963-967.
27. Richards, E. 1987. Preparation of genomic DNA from bacteria. Miniprep of bacterial genomic DNA, p. 1-2, unit 2.4.1. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
28. Sambrook, J., E. K. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
29. Sato, H., Y. Sato, A. Ito, and I. Ohishi. 1987. Effect of monoclonal antibody to pertussis toxin on toxin activity. Infect. Immun. 55:909-915.
30. Sato, Y., and H. Arai. 1972. Leukocytosis-promoting factor of Bordetella pertussis. I. Purification and characterization. Infect. Immun. 6:899-904.
31. Staendner, L. H., M. Rohde, K. N. Timmis, and C. A. Guzmán. 1995. Identification of Salmonella typhi promoters activated by invasion of eukaryotic cells. Mol. Microbiol. 18:891-902.
32. Stainer, D. W., and M. J. Scholte. 1970. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211-220.
33. Stein, P. E., A. Boodhoo, G. D. Armstrong, S. A. Cockle, M. H. Klein, and R. J. Read. 1994. The crystal structure of pertussis toxin. Structure 2:45-57.
34. Steinhoff, M. C., G. F. Reed, M. D. Decker, K. M. Edwards, J. A. Englund, M. E. Pichichero, M. B. Rennels, E. L. Anderson, M. A. Deloria, and B. D. Meade. 1995. A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines. Pediatrics 96:567-570.
35. Stibitz, S., A. A. Weiss, and S. Falkow. 1989. Phase variation in Bordetella pertussis by a frameshift in a gene for a novel two component system. Nature 338:266-269.
36. Tamura, M., K. Nogimori, S. Murai, M. Yajima, K. Ito, T. Katada, M. Ui, and S. Ishii. 1982. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry 21:5516-5522.
37. Walker, M. J., M. Rohde, J. Wehland, and K. N. Timmis. 1991. Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica. Infect. Immun. 59:4238-4248.
38. Walker, M. J., J. Wehland, K. N. Timmis, B. Raupach, and M. A. Schmidt. 1991. Characterization of murine monoclonal antibodies that recognize defined epitopes of pertussis toxin and neutralize its toxic effect on Chinese hamster ovary cells. Infect. Immun. 59:4249-4251.
39. Weiss, A. A., F. D. Johnson, and D. L. Burns. 1993. Molecular characterization of an operon required for pertussis toxin secretion. Proc. Natl. Acad. Sci. USA 90:2970-2974.
40. Witvliet, M. H., D. L. Burns, M. J. Brennan, J. T. Poolman, and C. R. Manclark. 1989. Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect. Immun. 57:3324-3330.
41. Yang, J., J. Mou, and Z. Shao. 1994. Structure and stability of pertussis toxin studied by in situ atomic force microscopy. FEBS Lett. 338:89-92.
42. Zealey, G. R., S. M. Loosmore, R. K. Yacoob, S. A. Cockle, A. B. Herbert, L. D. Miller, N. J. Mackay, and M. H. Klein. 1992. Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin. Appl. Environ. Microbiol. 58:208-214.